Revolution Medicines, Inc.
RVMDW- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001628171
In the last 90 days, Revolution Medicines, Inc. insiders filed 0 open-market purchases and 17 sales; 22 institutions reported holding it in 13F filings for Q2 2026, worth $93.0M in total; no superinvestor holds it.
Other share classesRVMD
13F holders, Q3 2025
Institutional positions in Revolution Medicines, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- −1 vs. Q2 2025
- Shares held
- 8.07M
- −11.5K (−0.1%) vs. Q2 2025
- Total value
- $2.40M
- +$286.6K (+13.5%) vs. Q2 2025
- New holders
- 0
- 1 more added
- Sold out
- 1
- 2 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RVMDW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 22 | $93.0M |
| Q1 2026 | 23 | $17.8M |
| Q4 2025 | 24 | $8.15M |
| Q3 2025 | 22 | $2.40M |
| Q2 2025 | 23 | $2.12M |
| Q1 2025 | 24 | $298.5K |
| Q4 2024 | 24 | $1.31M |
| Q3 2024 | 25 | $654.7K |
| Q2 2024 | 25 | $623.7K |
| Q1 2024 | 24 | $1.21M |
| Q4 2023 | 22 | $1.62M |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Revolution Medicines, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 200 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 64 | $18 | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 448 | $130 | 0.00% | 00.0% | Unchanged |
| TD Asset Management Inc | 40,636 | $12.2K | 0.00% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 70,349 | $21.1K | 0.00% | 00.0% | Unchanged |
| Weiss Asset Management LP | 73,640 | $22.1K | 0.00% | 00.0% | Unchanged |
| Farallon Capital Management, L.L.C. | 120,085 | $36.0K | 0.00% | 00.0% | Unchanged |
| Driehaus Capital Management LLC | 135,000 | $40.5K | 0.00% | 00.0% | Unchanged |
| Davidson Kempner Capital Management LP | 150,000 | $45.0K | 0.00% | 00.0% | Unchanged |
| DLK Investment Management, LLC | 164,477 | $49.3K | 0.02% | 00.0% | Unchanged |
| Sculptor Capital LP | 178,107 | $50.3K | 0.00% | 00.0% | Unchanged |
| Bleichroeder LP | 200,000 | $60.0K | 0.01% | 00.0% | Unchanged |
| Toronto Dominion Bank | 221,363 | $66.4K | 0.00% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 250,000 | $75.0K | 0.00% | 00.0% | Unchanged |
| Soros Capital Management LLC | 364,824 | $109.4K | 0.03% | 00.0% | Unchanged |
| Aristeia Capital LLC | 430,939 | $121.8K | 0.00% | +117,908+37.7% | Added |
| Lunate Capital Ltd | 450,000 | $135.0K | 0.06% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 500,000 | $149.9K | 0.00% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 595,935 | $179.0K | 0.00% | −3,366−0.6% | Reduced |
| D. E. Shaw & Co., Inc. | 1,454,895 | $436.5K | 0.00% | 00.0% | Unchanged |
| LMR Partners LLP | 2,646,023 | $793.5K | 0.01% | 00.0% | Unchanged |
| CSS LLC | 19,445 | – | – | −16,402−45.8% | Reduced |
| Cantor Fitzgerald, L. P. | 0 | $0 | 0.00% | −109,617−100.0% | Sold out |